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1. Introduction 
Bolton and Perutz [l] have demonstrated that 
the contact between hemoglobin unlike subunits 
(cllr/3*) undergoes drastic changes during the transi- 
tion from the oxy- to the deoxyform. The hydrogen 
bond between Asn G4 ( 102)PZ and Asp G 1(94)01, 
is the only polar interaction across the cylflZ interface 
in the normal oxyhemoglobin conformation. The 
rest of the interactions are non polar. Therefore, 
among the hemoglobin variants localized on this con- 
tact, hemoglobin Kansas G4 (102)fl Asn -+ Thr [ 21 
and hemoglobin Richmond G4 (102)/3 Asn + Lys [3] 
are of particular interest. The consequences of the 
modification of this unique olflZ polar bond was 
thoroughly studied by Greer [4] in the case of these 
two abnormal hemoglobins. 
A new example of disturbance of this hydrogen 
bond is reported in this paper: in Hb Setif, the resi- 
due Asp Gl (94)01 is substituted by a tyrosine. 
Moreover, the fact that the abnormality lies on the 
cr chain and that the new residue is a tyrosine, bears a 
genetic interest. 
2. Material and methods 
Blood was collected on heparin and hemolysate 
prepared by routine procedures. 
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The abnormal component was isolated by Bio Rex 
70 chromatography as previously described [ 51. The 
hemoglobin was deheminized and the chains sepa- 
rated. After amino-ethylation, the protein was sub- 
mitted to tryptic digestion. The peptides were sepa- 
rated and purified by ion exchange chromatography 
as described in [6]. 
The presence of an abnormal peptide, not clearly 
revealed on the elution pattern, was checked by the 
use of thin-layer analytical electrophoresis and 
chromatography. For this purpose, an aliquot of l/SO 
of each of the 8 first zones of the chromatography 
was submitted to an electrophoresis on cellulose thin- 
layers in pyridine-acetic buffer pH 6.4 and to a 
chromatography on silica gel thin-layers in iso-amyl 
alcohol, pyridine, water (35/35/27). 
All these runs were done simultaneously with the 
same zones of a normal (Y chain digest. Specific amino 
acid staining was performed on the thin layers. 
Amino acid composition was determined on a 
Beckman 120 C amino acid analyser and the sequence 
by the Edman-dansyl method of Gray [7], slightly 
modified, for ultra-micro procedure. 
3. Results and discussion 
An S-like moving component amounting to rough- 
ly 12% was found on starch gel electrophoresis at pH 
8.8, as well as a very faint component slower than 
AZ, which is in favor of a mutated cr chain. 
This localization was proved by chain separation 
of the purified abnormal component. 
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Fig. 1. Elution patiem of the aAE chain tryptic digest of Hb 
Setif (three-fold electrical amplification). One supplementary 
peak can be observed in zone VI. When analytical thin-layer 
electrophoresis and chromatography were performed on zone 
IV, one peptide was lacking, the supplementary peptide of 
zone VI was characteristic of tyrosine (see text). 
One supplementary peak was found on the elution 
pattern of the tryptic digest (fig. 1). Since the elution 
pattern of the amino ethylated (Y chain is rather com- 
plex, the presence of an abnormal peptide was also 
checked by analytical electrophoresis and chroma- 
tography on thin layers of the 8 first zones. In zone 
IV normally containing peptides aTr , oTs and aT1 l, 
one peptide was lacking; in zone VI, a supplementary 
peptide giving specific staining for tyrosine, was 
found. 
In view of the fact that the electrophoretic mobil- 
ity was different and that all the peptides containing 
tyrosine were in their normal position, and consider- 
ing the genetic code, the substitution was assumed to 
be Asp + Tyr in crTr 1. 
This was proved by the amino acid composition of 
the purified supplementary peptide (table 1) and the 
sequence determination. The abnormality of Hb Setif 
is localized on site G 1, one of the most important of 
the interface or&. Two fl chain variants have been 
described on the homologous_site: Hb Kempsey G 1 
(99)/I Asp + Asn [8] and Hb Yakima Gl (99)fl 
Asp + His [9]. Only four (Y chain mutants with a 
structural abnormality localized on this contact have 
been described up to now: 
Hb Chesapeake FG4 (92)(u Arg + Leu [ 101. 
Hb J Capetown FG4 (92)a.Arg + Glu [ 1 l] , 
Hb Georgia G2 (95)a Pro + Leu [ 121, and 
Hb Rampa G2 (95)a Pro + Ser [ 131. 
Table 1 
Amino acid composition of peptide 01 Tr r Setif. 
Lysine 
Aspartic acid 
Proline 
Valine 
Abnormal Normal 
pep tide oTr1 
1.1 1 
&J 2 
1.1 1 
1.7* 2 
Tyrosine QJ* 0 
Phenylalanine l.J 1 
* The lower recovery of valine and tyrosine may be explained 
by the sequence Val-Tyr- not completely hydrolysed in 
22hrin6NHC1at110°. 
All of these abnormal hemoglobins present a more 
or less important modification of the three dimen- 
sional structure of the protein. Therefore, they are 
very useful models for the understanding of the 
structure-function relationship of hemoglobin. The 
fact that the modified residue of Hb Se tif is involved 
in a bond changing during the oxy-deoxy transition 
confers a great interest to this model. 
Our preliminary data give evidence for an unsta- 
ble and functionally modified protein. Nevertheless 
the intraerythrocytic disorders are minor when com- 
pared to fl chain mutant ones. This can easily be ex- 
plained by the low percentage of the abnormal com- 
ponent due to the duplication of the CY gene. 
From the genetic point of view, two features have 
to be noticed: this mutant is an (Y chain mutant, and it 
is known that this category has a much lower fre- 
quency than fi chain mutants [ 141. This fact is ex- 
plainable by the constraints of its successive pairing 
with different other chains. Secondly, the substitu- 
tion of a tyrosine for an aspartic acid is most excep- 
tional. It leads to a drastic change together in polar- 
ity and in steric hindrance. The genetic code prevents 
such substitutions from happening frequently [ 151. 
It can be emphasized that transversions are rarely ob- 
served in the interior of the molecule, and that the 
mutation Asp + Tyr is due to a transversion of the 
first base from G to U. 
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